Inhibition of CXCR2 decreased tumor growth and angiogenesis in a genetic murine model of pancreatic ductal adenocarcinoma [195]
Secondly, we implemented several design features to mitigate biases: we defined a causal framework, used direct acyclic graphs to guide the selection of confounders, specified new user, active comparator target trials, and used inverse probability weighting to adjust for a comprehensive set of covariates from multiple data domains
The SURMOUNT-1 trial showed that while average weight loss at 72 weeks reached 1521% depending on dose, the trajectory was not linear, with many participants experiencing temporary plateaus
Some users experience nausea, indigestion, bloating, or stomach discomfort, particularly when taking pills on an empty stomach